Getty Images
Woman dies in Virginia after receiving COVID vaccine from Johnson & Johnson: another person is in critical condition
The alarm went off in the United States on Tuesday, after the CDC (Centers for Disease Control and Prevention) and the FDA (Food and Drug Administration in the United States) revealed that of the nearly 7 million doses that were from Johnson & Johnson’s COVID vaccine , 6 people reported suffering from a worrying side effect – blood clots. For this reason, they have requested the temporary suspension of the application of this drug, until they fully investigate the cases.
Worst of all, of the six people who had serious side effects after receiving the dose of J&J, one of them, a woman from the state of Virginia, died.
Another, from the state of Nebraska, is in a critical condition in a hospital, as revealed by the New York Times.
The above-mentioned media added that both the deceased woman who received the Johnson & Johnson vaccine and the one who is hospitalized, as well as the other four remaining, were all female patients, between 18 and 48 years old.
FOX News revealed that health authorities are investigating the death of the woman, whose identity has not been revealed, in a larger investigation they launched to find out more about the “side effects” of the Johnson & Johnson vaccine. Reported so far,
FOX quoted Virginia vaccination coordinator Danny Avula as confirming that the woman’s death occurred in March last year and is being investigated to determine whether or not there were any effects that could have occurred with the Johnson & Vaccine. Johnson. .
The official warned that when the woman died, she was reported to the CDC’s adverse event notification system.
“We are closely following the federal government’s efforts to stop all Johnson & Johnson vaccines while investigating a possible extremely rare side effect. In Virginia, we will stop all Johnson & Johnson vaccines until this investigation is completed, “the official said in a statement.
“This break is reassuring because it shows that the systems that exist to monitor the safety of the vaccine are working. We expect a thorough review by federal health officials. In the meantime, we will continue to launch the Virginia vaccine at this time with the other two licensed vaccines, developed by Pfizer and Moderna, “he added.” People who have received the Johnson & Johnson vaccine and who develop severe headaches, abdominal pain, pain or three months after vaccination should contact their healthcare provider or call 911 if it is a medical emergency. ”
As for the woman who is in serious condition in the state of Nebraska, the local television news 6 News assured that she is a 48-year-old woman “vaccinated with Johnson & Johnson Lot No. 1805020 on March 9”.
Regarding her condition, the aforementioned media said: “she is currently hospitalized with deep bleeding and coagulation, suspected of dysfibrinogenemia”. The CDC’s report, through the vaccine adverse event reporting system, known as VAERS, lists the woman’s condition as severe and life-threatening.
Following the release of the Johnson & Johnson vaccine, Dr. Peter Marks, director of the FDA’s Center for Biological Research and Evaluation, and Dr. Anne Schuchat, deputy director general of the CDC, said in a statement:
“People who have received the J&J vaccine and develop severe headaches, abdominal pain, leg pain or shortness of breath within three weeks of vaccination should contact their healthcare provider.”
“Healthcare providers are asked to report adverse events to the vaccine adverse event reporting system at https://vaers.hhs.gov/reportevent.html,” they added.
Officials added: “At the moment, these adverse events appear to be extremely rare. The safety of the COVID-19 vaccine is a top priority for the federal government, and we take all reports of health problems after COVID-19 vaccination very seriously. “
FDA and @CDCgov issued a statement on the Johnson & Johnson vaccine for # COVID-19. We recommend a break from using this vaccine as a precaution. https://t.co/EOaNEScaRL
– US FDA in Spanish (@FDAenEspanol) April 13, 2021
Regarding the findings in the six reported cases, they stated: “In these cases, a type of blood clot called cerebral venous sinus thrombosis (CVST) was observed in combination with low levels of platelets in the blood (thrombocytopenia). All six cases occurred among women aged 18 to 48 years, and symptoms occurred 6 to 13 days after vaccination. The treatment for this specific type of blood clot is different from the treatment that is normally given. Usually, a thin drug called heparin is used to treat blood clots. In this context, the administration of heparin can be dangerous and it is necessary to administer alternative treatments “.
Follow the same on Instagram now
